Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 8 studies | 23% ± 5% | |
macrophage | 6 studies | 27% ± 8% | |
endothelial cell | 4 studies | 19% ± 1% | |
microglial cell | 4 studies | 27% ± 7% | |
alveolar macrophage | 3 studies | 20% ± 3% | |
astrocyte | 3 studies | 27% ± 4% | |
glutamatergic neuron | 3 studies | 38% ± 17% | |
renal principal cell | 3 studies | 39% ± 10% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 38% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1434.31 | 2641 / 2642 | 100% | 28.94 | 705 / 705 |
adrenal gland | 100% | 1663.83 | 258 / 258 | 100% | 28.38 | 229 / 230 |
thymus | 100% | 1025.37 | 652 / 653 | 99% | 30.67 | 600 / 605 |
prostate | 100% | 1262.33 | 244 / 245 | 99% | 32.26 | 499 / 502 |
kidney | 100% | 1741.15 | 89 / 89 | 98% | 31.36 | 887 / 901 |
pancreas | 100% | 1134.89 | 327 / 328 | 97% | 26.05 | 173 / 178 |
liver | 100% | 1633.30 | 226 / 226 | 97% | 18.70 | 392 / 406 |
lung | 100% | 1167.97 | 577 / 578 | 96% | 26.38 | 1112 / 1155 |
intestine | 100% | 1135.44 | 966 / 966 | 94% | 17.87 | 498 / 527 |
esophagus | 100% | 876.07 | 1444 / 1445 | 95% | 23.22 | 173 / 183 |
stomach | 100% | 702.61 | 359 / 359 | 94% | 18.90 | 268 / 286 |
breast | 100% | 1087.44 | 459 / 459 | 92% | 20.04 | 1026 / 1118 |
skin | 97% | 959.36 | 1761 / 1809 | 94% | 19.56 | 443 / 472 |
bladder | 100% | 957.19 | 21 / 21 | 89% | 19.76 | 449 / 504 |
uterus | 100% | 1122.92 | 170 / 170 | 84% | 15.96 | 387 / 459 |
ovary | 100% | 913.06 | 180 / 180 | 78% | 9.10 | 337 / 430 |
adipose | 100% | 1230.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 57.26 | 29 / 29 |
spleen | 100% | 1491.90 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.56 | 1 / 1 |
blood vessel | 100% | 1221.13 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 489.33 | 826 / 861 | 0% | 0 | 0 / 0 |
muscle | 92% | 379.62 | 741 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 80% | 11.23 | 64 / 80 |
tonsil | 0% | 0 | 0 / 0 | 80% | 11.38 | 36 / 45 |
peripheral blood | 64% | 907.30 | 590 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0045616 | Biological process | regulation of keratinocyte differentiation |
GO_0097193 | Biological process | intrinsic apoptotic signaling pathway |
GO_0006670 | Biological process | sphingosine metabolic process |
GO_0030149 | Biological process | sphingolipid catabolic process |
GO_0006668 | Biological process | sphinganine-1-phosphate metabolic process |
GO_0045682 | Biological process | regulation of epidermis development |
GO_0046839 | Biological process | phospholipid dephosphorylation |
GO_0035621 | Biological process | ER to Golgi ceramide transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0070780 | Molecular function | dihydrosphingosine-1-phosphate phosphatase activity |
GO_0042392 | Molecular function | sphingosine-1-phosphate phosphatase activity |
Gene name | SGPP1 |
Protein name | Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1) (Sphingosine-1-phosphate phosphohydrolase 1) (SPP-1) |
Synonyms | SPP1 |
Description | FUNCTION: Specifically dephosphorylates sphingosine 1-phosphate (S1P), dihydro-S1P, and phyto-S1P. Does not act on ceramide 1-phosphate, lysophosphatidic acid or phosphatidic acid . Sphingosine-1-phosphate phosphatase activity is needed for efficient recycling of sphingosine into the sphingolipid synthesis pathway . Regulates the intracellular levels of the bioactive sphingolipid metabolite S1P that regulates diverse biological processes acting both as an extracellular receptor ligand or as an intracellular second messenger . Involved in efficient ceramide synthesis from exogenous sphingoid bases. Converts S1P to sphingosine, which is readily metabolized to ceramide via ceramide synthase. In concert with sphingosine kinase 2 (SphK2), recycles sphingosine into ceramide through a phosphorylation/dephosphorylation cycle (By similarity). Regulates endoplasmic-to-Golgi trafficking of ceramides, resulting in the regulation of ceramide levels in the endoplasmic reticulum, preferentially long-chain ceramide species, and influences the anterograde membrane transport of both ceramide and proteins from the endoplasmic reticulum to the Golgi apparatus . The modulation of intracellular ceramide levels in turn regulates apoptosis (By similarity). Via S1P levels, modulates resting tone, intracellular Ca(2+) and myogenic vasoconstriction in resistance arteries . Also involved in unfolded protein response (UPR) and ER stress-induced autophagy via regulation of intracellular S1P levels . Involved in the regulation of epidermal homeostasis and keratinocyte differentiation (By similarity). . |
Accessions | ENST00000645915.2 ENST00000247225.7 Q9BX95 |